Area of research
Psychiatry and Mental health · Physiology
Research interest
Research focused on Frontotemporal dementia and Frontotemporal lobar degeneration, with related work in Dementia, Progressive supranuclear palsy, Disease. Notable publications include 'Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis', 'Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial', and 'Utility of the global CDR ® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium'.
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders
Effect of Structured, Moderate Exercise on Kidney Function Decline in Sedentary Older Adults
ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
Current directions in tau research: Highlights from Tau 2020
Utility of the global CDR<sup>®</sup> plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases
Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration
Revised Self-Monitoring Scale
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint
Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
Association of Accelerometry‐Measured Physical Activity and Cardiovascular Events in Mobility‐Limited Older Adults: The LIFE (Lifestyle Interventions and Independence for Elders) Study
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial